One of them, Plexin domain containing 2 (Plxdc2), was chosen and further confirmed to have an immunoregulatory role with the potential to be used as molecular target for the development of treatments for inflammatory and autoimmune diseases. This evidence concerns the gene PLXDC2 and autoimmune disease.